PMDA drug package insert
ナトリックス錠1
PMDA Prescription drug · 京都薬品工業株式会社 · package insert Apr 24, 2026
Key facts
| Brand names | ナトリックス錠1, ナトリックス錠2 |
|---|---|
| Nonproprietary names | インダパミド |
| Companies | 製造販売元／京都薬品工業株式会社, 販売元／住友ファーマ株式会社, 発売元／日本セルヴィエ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 持続型非チアジド系降圧剤 |
| Therapeutic category codes | 872149 |
| YJ codes | 2149012F1059, 2149012F2020 |
| Approval numbers | 21400AMZ00038, 20200AMZ00793 |
| Package insert edition | 第3版 |
| Package insert date | Apr 24, 2026 |
| PMDA document key | 230099_2149012F1059_1 |
| PMDA company code | 230099 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: